Cynata announces presentation of data demonstrating consistency of its MSCs

Cynata chief operating officer Dr Kilian Kelly said, “The overall conclusion of the study is that Cymerus MSCs are highly consistent and that the Cymerus manufacturing process successfully bypasses much of the inherent variability that affects tissue-derived MSCs." …